Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2023-2029

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2023-2029

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
LPI (LP Information)' newest research report, the “Anti-inflammatory Therapeutics Industry Forecast” looks at past sales and reviews total world Anti-inflammatory Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-inflammatory Therapeutics sales for 2023 through 2029. With Anti-inflammatory Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-inflammatory Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Anti-inflammatory Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-inflammatory Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-inflammatory Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-inflammatory Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-inflammatory Therapeutics.
The global Anti-inflammatory Therapeutics market size is projected to grow from US$ 108140 million in 2022 to US$ 166150 million in 2029; it is expected to grow at a CAGR of 6.3% from 2023 to 2029.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Segmentation by application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA

Please note: The report will take approximately 2 business days to prepare and deliver.